< Back to companies
Oxford Cancer Analytics

Oxford Cancer Analytics

Oxford, United Kingdom

Oxford Cancer Analytics is on a mission to enable curative cancer treatments through early detection. OXcan's machine learning platform enables minimally invasive and inexpensive cancer screening in high risk populations through analysing cancer materials shed into the blood. OXcan hopes to create a paradigm shift in screening and eventually replacing invasive tissue biopsy and expensive, complex imaging as the current standard of care. It is safer, cheaper, and detects cancers much earlier, when they are still curable.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2020
Website
www.oxcan.org/

Categories

CancerScreening & Early DetectionDiagnosticsAI / ML

Disease Areas

Technologies

Machine LearningLiquid BiopsyAI in DiagnosticsDiagnostic Platforms
Only accessible to MedStartr community members. Join now

What do you think of Oxford Cancer Analytics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now